Back to GABELLI FUNDS LLC GABELLI FUNDS LLC

EIDXEIDX
2 quarters

Position history for GABELLI FUNDS LLCGABELLI FUNDS LLC's holdings in EIDOS THERAPEUTICS INC

As of its Q4 2020 13F, Gabelli Funds held 39,400 shares of EIDX (Eidos Therapeutics), worth $5.2M.

Final Value

$0

Final Shares

0

Total Value Change

-$5.2M

Total Shares Change

-39,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q4
New
39,400
-
$5.2M0.0%—
37

Other major holders of EIDX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used